Population growth places the United States in a radically different position from that of Russia, Japan and Europe. Q. Sakamaki / Redux Estimates of the United states population at the middle of the ...

The grand finale of Vision Mysuru 2050, a student-driven civil-centric initiatives of SDM Institute for Management Development (SDMIMD) in Mysuru, will be held on Monday at 4 p.m. on the SDMIMD campus ...

Burlington is moving forward with its Horizon 2050 vision plan following committee discussions that highlighted both strong support and debate over how the city defines environmental priorities.

Scientists expect 41% of the projected global population to face the extremes, with ‘no part of the world’ immune The number of people living with extreme heat will more than double by 2050 if global ...

Artificial intelligence could fundamentally reshape education over the next three decades, potentially making many traditional cognitive tasks optional for students, according to experts at the ...

If Berlin were to become a climate-neutral city within the next 25 years, daily life could be radically different. Foreword: Though the character Emilia is fictional, this vision of life in Berlin in ...

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that written materials accompanying the Company’s upcoming presentation at the BofA Securities 2025 Global Real Estate Conference ...

Over the last century, L.A.’s love affair with the single-family home has created a suburban sprawl of epic proportions. Three bedrooms. A white-picket fence. A square of grass for the barbecue. But ...

After eight years on the drawing board, Orange County’s rewritten blueprint for growth goes to county commissioners Tuesday for a final review of the effort to slow sprawl and protect rural areas ...

Businesses and professional firms use presentations to inform, educate, motivate and persuade internal and external audiences. They build presentations into sales, training and internal communication ...

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with ...